Progenitor cell activation in chronic viral hepatitis

Liver International

Volumn 24, Issue 3, 2004, Pages 268-274

  Fotiadu, Anastasia ^a   Tzioufa, Valentini ^a   Vrettou, Eleni ^a   Koufogiannis, Dimitrios ^a   Papadimitriou, Constantine S ^a   Hytiroglou, Prodromos ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Chronic hepatitis B; Chronic hepatitis C; Cytokeratin 7; Oval cells; Progenitor cells; Regeneration

Indexed keywords

CYTOKERATIN 7;

ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL MODEL; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; LIVER REGENERATION; PATHOGENESIS; STAGING; STEM CELL; TISSUE SECTION;

EID: 3142698523     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.00908.x     Document Type: Article

References (46)

1. Farber E. Similarities in the sequence of early histologic changes induced in the livers of rats by ethionine, 2-acetyl-aminofluorene and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res 1956; 16: 142-8.
2. Opie E L. The pathogenesis of tumours in the liver produced by butter yellow. J Exp Med 1944; 80: 231-46.
3. Sell S. Comparison of liver progenitor cells in human atypical ductular reactions with those seen in experimental models of liver injury. Hepatology 1998; 27: 317-31.
4. Hsia C, Evarts R P, Nakatsukasa H, Marsden E R, Thorgeirsson S S. Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 1992; 16: 1327-33.
5. Hsia C, Thorgeirsson S S, Tabor E. Expression of hepatitis B surface and core antigens and transforming growth factor-α in 'oval cells' of the liver in patients with hepatocellular carcinoma. J Med Virol 1994; 43: 216-21.
6. Roskams T, de Vos R, van Eyken P, Myazaki H, Van Damme B, Desmet V. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol 1998; 29: 455-63.
7. Sell S. Is there a liver stem cell? Cancer Res 1990; 50: 3811-15.
8. Germain L, Blouin M J, Marceau N. Biliary epithelial and hepatocytic cell lineage relationships in embryonic rat liver as determined by the differential expression of cytokeratins, alpha-fetoprotein, albumin, and cell surface-exposed components. Cancer Res 1988; 48: 4909-18.
9. Sell S. Liver stem cells. Mod Pathol 1994; 7: 105-12.
10. Alison M, Sarraf C. Hepatic stem cells. J Hepatol 1998; 29: 676-82.
11. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001; 33: 738-50.
12. Gerber M, Thung S, Shen S, Stromeyer W, Ishak K. Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol 1983; 110: 70-4.
13. Demetris A J, Seaberg E C, Wennerberg A, Ionellie J, Michalopoulos G. Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. Am J Pathol 1996; 149: 439-48.
14. Hixson D, Chapman L, McBride A, Faris R, Yang L. Antigenic phenotypes common to rat oval cells, primary hepatocellular carcinomas and developing bile ducts. Carcinogenesis 1997; 18: 1169-75.
15. Roskams T, de Vos R, van Den Oord J, Desmet V. Cells with neuroendocrine features in regenerating human liver. APMIS Suppl 1991; 23: 32-9.
16. Radaeva S, Steinberg P. Phenotype and differentiation patterns of the oval cell lines OC/CDE 6 and OC/CDE 22 derived from the livers of carcinogen-treated rats. Cancer Res 1995; 55: 1028-38.
17. Anilkumar T V, Golding M, Edwards R, Lalani E N, Sarraf C, Alison M. The resistant hepatocyte model of carcinogenesis in the rat: the apparent independent development of oval cell proliferation and early nodules. Carcinogenesis 1995; 16: 845-53.
18. Lemire J, Shiojiri N, Fausto N. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol 1991; 139: 535-52.
19. Braun L, Mikumo R, Fausto N. Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res 1989; 49: 1554-61.
20. Evarts R P, Nakatsukasa H, Marsden E R, Hsia C C, Dunsford H A, Thorgeirsson S S. Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat. Cancer Res 1990; 50: 3439-44.
21. Evarts R P, Nakatsukasa H, Marsden E R, Hu Z, Thorgeirsson S S. Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol Carcinogenesis 1992; 5: 25-31.
22. Marsden E R, Hu Z, Fujio K, Nakatsukasa H, Thorgeirsson S S, Evarts R P. Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest 1992; 67: 427-33.
23. Bisgaard H C, Nagy P, Santoni-Rugiu E, Thorgeirsson S. Proliferation, apoptosis, and induction of hepatic transcription factors are characteristics of the early response of biliary epithelial (oval) cells to chemical carcinogens. Hepatology 1996; 23: 62-70.
24. Sell S, Salman J. Light- and electron-microscopic autoradiographic analysis of proliferating cells during the early stages of chemical hepatocarcinogenesis in the rat induced by feeding N-2-fluorenylacetamide in a choline-deficient diet. Am J Pathol 1984; 114: 287-300.
25. Roskams T, van Den Oord J, de Vos R, Desmet V. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol 1990; 137: 1019-25.
26. deVos R, Desmet V. Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction. Am J Pathol 1992; 140: 1441-50.
27. Lenzi R, Liu M, Tarsetti F, Slott P, Alpini G, Zhai W R, Paronetto F, Lenzen R, Tavoloni N. Histogenesis of bile duct-like cells proliferating during ethionine hepatocarcinogenesis. Evidence for a biliary epithelial nature of oval cells. Lab Invest 1992; 66: 390-402.
28. Xiao J C, Ruck P, Kaiserling E. Small epithelial cells in extrahepatic biliary atresia: electron microscopic and immunoelectron microscopic findings suggest a close relationship to liver progenitor cells. Histopathology 1999; 35: 454-60.
29. Phillips M, Poucell S. Modern aspects of the morphology of viral hepatitis. Hum Pathol 1991; 145: 375-83.
30. Tan J, Hytiroglou P, Wieczorek R, Park Y N, Thung S N, Arias B, Theise N D. Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver 2002; 22: 365-73.
31. Koukoulis G, Rayner A, Tan K C, Williams R, Portmann B. Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol 1992; 166: 359-68.
32. Crosby H, Hubscher S, Fabris L, Joplin R, Sell S, Kelly D, Strain A. Immunolocalization of putative human liver progenitor cells in livers from patients with endstage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol 1998; 152: 771-9.
33. Vandersteenhoven A, Burchette J, Michalopoulos G. Characterization of ductular hepatocytes in end-stage cirrhosis. Arch Pathol Lab Med 1990; 114: 403-6.
34. Roskams T, de Vos R, Desmet V. 'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology 1996; 28: 291-9.
35. Ruck P, Xiao J C, Pietsch T, Von Schweinitz D, Kaiserling E. Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6. Histopathology 1997; 31: 324-9.
36. Fiel I, Antonio L, Nalesnik M, Thung S, Gerber M. Characterization of ductular hepatocytes in primary liver allograft failure. Mod Pathol 1997; 10: 348-53.
37. Knodell R G, Ishak K G, Black W C, Chen T S, Craig R, Kaplowitz N, Kiernan T W, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
38. Desmet V J, Gerber M, Hoofnagle J H, Manns M, Scheuer P J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
39. Hsu S M, Raine L. Protein A, avidin and biotin in immunohistochemistry. J Histochem Cytochem 1981; 29: 1349-53.
40. Petersen B, Bowen W, Patrene K, Mars W, Sullivan A, Murase N, Boggs S, Greenberger J, Goff J. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-70.
41. Theise N, Nimmakayalu M, Gardner R, Illei P, Morgan G, Teperman L, Henegariu O, Krause D. Liver from bone marrow in humans. Hepatology 2000; 32: 11-6.
42. Libbrecht L, Desmet V, van Damme B, Roskams T. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol 2000; 192: 373-8.
43. Lowes K, Brennan B, Yeoh G, Olynyk J. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154: 537-41.
44. Miyazaki H, van Eyken P, Roskams T, de Vos R, Desmet V. Co-proliferation of 'oval' cells and fat-storing cells-myofibroblasts in the rat liver during chemical hepatocarcinogenesis: an immunohistochemical study. In: Knook D L, Wisse E, eds. Cells of the Hepatic Sinusoid. Kupffer Cell Foundation: Leiden, 1993; 526-9.
45. Yin L, Lynch D, Ilic Z, Sell S. Proliferation and differentiation of ductular progenitor cells and littoral cells during the regeneration of the rat liver to CC14/2-AAF injury. Histol Histopathol 2002; 17: 65-81.
46. Ambu R, Costa V, Demelia L, Faa G, Farci A M G, Liguori C, Parodo G, Pilleri G, van Eyken P. Ductular reaction and oval cell proliferation in chronic hepatitis C. J Hepatol 1995; 23(Suppl. 1): 192.